BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...

Radiation oncology, neuro-oncology, and thoracic medical oncology specialists at Memorial Sloan Kettering Cancer Center (MSK) are conducting three clinical trials of new SRS strategies for patients ...

This trial is looking at dostarlimab by itself and with other immunotherapies. The other immunotherapies are belrestotug and GSK6097608. It is open to people with non small cell lung cancer that has ...

Candel Therapeutics has identified a subpopulation of lung cancer patients living longest on its oncolytic virus, leading the biotech to narrow its focus as it heads towards a potentially ...